Ascophyllum nodosum

夜蛾
  • 文章类型: Review
    家庭牙科护理是兽医患者牙周治疗的关键要素。在许多被动家庭牙科护理策略中,有一种补充动物饮食的海藻结鞘草已被证明可以减少狗和猫口服后的结石和牙菌斑积累。夜蛾含有许多生物活性成分,包括微量元素,维生素,和其他几种化合物,然而,其有益作用的确切机制仍不清楚。最初的代谢组学数据表明,它可以改变狗唾液的组成。已根据兽医口腔健康委员会提供的标准和要求对几种含有结鞘草的产品进行了临床评估。在狗和猫中进行的临床试验表明,结鞘藻作为粉末发挥最强的预防作用,其次是牙齿咬伤和干宠物食品。有关其治疗作用的数据仅限于一项在猫中的研究,其中未观察到有益作用。根据现有的临床数据,建议在口腔预防程序后对狗和猫施用结节性星藻,以减少斑块和结石形成的复发。
    Home dental care is a key element of periodontal therapy in veterinary patients. Among many strategies of passive home dental care there is a supplementation of animal diet with seaweed Ascophyllum nodosum which have been shown to reduce both calculus and plaque accumulation after oral administration in both dogs and cats. Ascophyllum nodosum contains numerous biologically active ingredients, including micro-elements, vitamins, and several other compounds, however the exact mechanism of its beneficial action remains unclear. The very first metabolomic data suggest that it could change the composition of dog saliva. Several products containing Ascophyllum nodosum had been assessed clinically according to standards and requirements provided by the Veterinary Oral Health Council. The conducted clinical trials in dogs and cats revealed that Ascophyllum nodosum exerts the strongest preventive action as powder, followed by dental bites and dry pet food. The data concerning its curative action are limited to one study in cats in which no beneficial action has been observed. Based on available clinical data it is recommended to administer Ascophyllum nodosum to dogs and cats after oral cavity prophylactic procedure to reduce the recurrence of plaque and calculus formation.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

    求助全文

  • 文章类型: Journal Article
    代谢综合征(MetS)是一个全球性的公共卫生问题,影响了世界人口的近25.9%,其特征是以腹部肥胖为主的一系列疾病。高血压,空腹血糖高,高三酰基甘油血症和低HDL-胆固醇。近年来,海洋生物,尤其是海藻,已被强调为生物活性化合物和有用代谢物的潜在天然来源,具有许多生物和生理活性,可用于功能性食品或人类营养品中,以管理MetS和相关疾病。在三组海藻中,已知棕色海藻比红色和绿色海藻含有更多的生物活性成分。在不同的棕色海藻种类中,夜蛾和云杉具有最高的抗氧化值和最高的总酚含量。然而,证据基础主要依赖于细胞系和小动物模型,迄今为止很少有涉及人类的研究。这篇综述旨在概述褐藻提取物夜蛾和岩藻在管理和预防MetS及相关疾病方面的潜力,基于从临床试验中获得的现有证据。
    Metabolic syndrome (MetS) is a global public health problem affecting nearly 25.9% of the world population characterised by a cluster of disorders dominated by abdominal obesity, high blood pressure, high fasting plasma glucose, hypertriacylglycerolaemia and low HDL-cholesterol. In recent years, marine organisms, especially seaweeds, have been highlighted as potential natural sources of bioactive compounds and useful metabolites, with many biological and physiological activities to be used in functional foods or in human nutraceuticals for the management of MetS and related disorders. Of the three groups of seaweeds, brown seaweeds are known to contain more bioactive components than either red and green seaweeds. Among the different brown seaweed species, Ascophyllum nodosum and Fucus vesiculosus have the highest antioxidant values and highest total phenolic content. However, the evidence base relies mainly on cell line and small animal models, with few studies to date involving humans. This review intends to provide an overview of the potential of brown seaweed extracts Ascophyllum nodosum and Fucus vesiculosus for the management and prevention of MetS and related conditions, based on the available evidence obtained from clinical trials.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

       PDF(Sci-hub)

       PDF(Pubmed)

公众号